- Healthia (HLA) is set to purchase Natural Fit Footware and three physiotherapy clinics in North Queensland for around $3.3 million
- Natural Fit Footware is a speciality footwear retailer which includes six stores and an e-commerce site
- The footwear retailer is expected to bring in a revenue of around $6.1 million to Healthia
- Additionally, Healthia will purchase three physiotherapy clinics in Northern Queensland
- The company has also completed its recent purchase of one podiatry clinic in South Australia and the CQ Physio Group
- On market close, Healthia remains in the grey and trading for $1.03 per share
Healthia (HLA) is set to purchase Natural Fit Footware and three physiotherapy clinics in North Queensland for around $3.3 million.
The company has entered into agreements to purchase Natural Fit Footwear, a speciality footwear retailer. Natural Fit Footwear includes six stores – five in New South Wales and one in Victoria – and an online website.
The footwear retailer will fit in with Healthia’s podiatry division, where the company currently owns and operates 10 retail footwear stores.
“In addition, Healthia will use the established e-commerce platform created by
Natural Fit Footwear to extend an online retail footwear offering to the patients of its 94 podiatry clinics,” the company told the market.
National Fit Footwear was created in 2017 and retails brands such as Ecco, Klouds, Frankie4, Revere, Vionic, Skechers, Saucony and Birkenstock.
The footwear stores and e-commerce platform is expected to bring in a revenue of around $6.1 million.
Additionally, Healthia will purchase three physiotherapy clinics in Northern Queensland, dubbed North Queensland Physiotherapy Centre. The Queensland stores are expected to bring in a revenue of nearly $2 million.
Settlement of physiotherapy clinics is expected to be completed before the end of the year.
Healthia has also completed its recent purchase of one podiatry clinic in South Australia and the CQ Physio Group.
On market close, Healthia remains in the grey and trading for $1.03 per share.